Palmitato isopropilico, minimo 90%, per sintesi, 250 ml, confezione in plastica.

(2R,4S,5R)-4-(hydroxymethyl)-2-phenyl-1,3-dioxan-5-ol, 98%, 500mg

(4R,4'R)-2,2'-(2,3-Dihydro-1H-indene-2,2-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole), 97%, 1g

ethyl 2-(3-cyclopropyl-6-oxopyridazin-1(6H)-yl)acetate, 95.0%, 250mg

6-BROMO-5-FLUORO-2(1H)-QUINAZOLINONE, 97.0%, 250mg

1-Octadecene>90.0%(GC)500mL

5-Bromo-3-chloro-7h-pyrrolo[2,3-c]pyridazine, 97%, 100mg

5-Hexen-1-ol, 95.0%, 10g

TERT-BUTYL 1-CARBAMOYL-6-AZASPIRO[2.5]OCTANE-6-CARBOXYLATE, 95.0%, 5g

6-Methoxybenzothiazole, 97.0%, 1g

2-Bromo-5-iodo-m-xylene, 98.0%, 5g

2-Amino-8-methyl-1,7-dihydro-6H-purin-6-one, 97%, 100mg

METHYL 2-(OXAN-4-YL)-1H-IMIDAZOLE-4-CARBOXYLATE, 95.0%, 1g